SUNNYVALE, Calif., Feb. 1, 2012 /PRNewswire/ -- Cepheid (NASDAQ:
CPHD) today announced that its executives will be speaking at the
following investor conferences, and invited investors to
participate via webcast.
Leerink Swann Global Healthcare Conference, New York, NY
Wednesday, February 15, 2012 at
11.30 a.m. Eastern Time
Raymond James Annual Conference, Orlando, FL
Tuesday, March 6, 2012 at
1.05 p.m. Eastern Time
Additionally, Cepheid announced that it will participate in The
NASDAQ Opening Bell ceremony at The NASDAQ Stock Market on
Tuesday, February 7, 2012. The
ceremony commemorates the continued growth and innovation of
Cepheid's GeneXpert® system which saw record placements in 2011,
and will take place at 9:30 a.m. Eastern
Time at The NASDAQ MarketSite Studio in Times Square,
New York City.
Accessing Live Webcasts
To access the live webcasts for the two investor conferences,
please visit Cepheid's website at www.cepheid.com/investors at
least 15 minutes before the scheduled start time to download any
necessary audio or plug-in software. A replay of the webcasts
will be available shortly following the presentation and will
remain available for at least 90 days.
About Cepheid
Based in Sunnyvale, Calif.,
Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company
that is dedicated to improving healthcare by developing,
manufacturing, and marketing accurate yet easy to use molecular
systems and tests. By automating highly complex and time-consuming
manual procedures, the company's solutions deliver a better way for
institutions of any size to access the full power of molecular
diagnostics. The company's systems enable rapid, sophisticated
genetic testing for organisms and genetic-based diseases by
automating otherwise complex manual laboratory procedures. Through
its strong molecular biology capabilities, the company is focusing
on those applications where accurate, rapid, and actionable test
results are needed most, such as managing infectious diseases and
cancer. For more information, visit www.cepheid.com.
|
CONTACTS:
|
|
|
|
For
Media Inquiries:
|
For
Investor Inquiries:
|
|
|
Jared
Tipton
Cepheid
Corporate Communications
Tel: (408)
400-8377
communications@cepheid.com
|
Jacquie
Ross
Cepheid
Investor Relations
Tel: (408)
400-8329
investor.relations@cepheid.com
|
|
SOURCE Cepheid